例如:"lncRNA", "apoptosis", "WRKY"

SIPAR negatively regulates STAT3 signaling and inhibits progression of melanoma.

Cell. Signal.2013 Nov;25(11):2272-80. Epub 2013 Jul 31
Fangli Ren 1 , Fuqin Su , Hongxiu Ning , Yangmeng Wang , Yongtao Geng , Yarui Feng , Yinyin Wang , Yanquan Zhang , Zhe Jin , Yi Li , Baoqing Jia , Zhijie Chang
Fangli Ren 1 , Fuqin Su , Hongxiu Ning , Yangmeng Wang , Yongtao Geng , Yarui Feng , Yinyin Wang , Yanquan Zhang , Zhe Jin , Yi Li , Baoqing Jia , Zhijie Chang
+ et al

[No authors listed]

Author information
  • 1 State Key Laboratory of Biomembrane and Membrane Biotechnology, School of Medicine, School of Life Sciences, Tsinghua University, Beijing 100084, China.

摘要


Persistently activated is important for tumorigenesis in a variety of cancers, including melanoma. Although many co-factors in the regulation of duanyu18133 activity have been identified, it remains unclear how duanyu18133 phosphorylation is negatively regulated. Here, we report that SIPAR Protein As a Repressor) inhibits duanyu18133 activity by accelerating its dephosphorylation. We observed that SIPAR directly interacted with duanyu18133 upon IL-6 stimulation. Moreover, over-expression of SIPAR reduced, whereas depletion enhanced, the level of phosphorylated We further demonstrated that SIPAR inhibited the growth of melanoma cells by decreasing the level of phosphorylated duanyu18133 and the expression of its target genes. These results suggest that SIPAR, functioning as a new negative regulator, inhibits duanyu18133 activity by enhancing its dephosphorylation and represses melanoma progression.

KEYWORDS: Dephosphorylation, Melanoma, SIPAR, STAT3